CC BY-NC-ND 4.0 · Ultrasound Int Open 2022; 08(01): E22-E28
DOI: 10.1055/a-1781-4410
Original Article

Transabdominal Ultrasound and Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Observational Retrospective Single-Center Study

Lenika Calavrezos
1   Department of Internal Medicine and Gastroenterology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Peter Bannas
2   Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf Center for Diagnostics, Hamburg, Germany
,
Malte Warncke
2   Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf Center for Diagnostics, Hamburg, Germany
,
Christiane Wiegard
1   Department of Internal Medicine and Gastroenterology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Samuel Huber
1   Department of Internal Medicine and Gastroenterology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Carolin Manthey
1   Department of Internal Medicine and Gastroenterology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
› Author Affiliations

Abstract

Purpose Transabdominal ultrasound (US) and magnetic resonance enterography (MRE) are used to assess disease activity and extent in IBD, but their impact on therapeutic decisions is unclear. Therefore, our study has two goals: to compare the usefulness of US and MRE in assessing disease extent and activity in the small and large bowel, and to determine the relevance for clinical decisions in IBD.

Materials and Methods We included 54 IBD patients who had undergone both MRE and US within three months. We used the construct reference standard model to compare MRE and US for detecting inflammation and examined the impact on clinical decisions in IBD patients.

Results In 54 IBD patients (44 patients Crohn’s disease (CD), 5 ulcerative colitis (UC), 5 indeterminate colitis (IC)), 42 patients (77.8%) showed inflammation either in the small or large bowel. Small bowel disease was present in 34 patients (77.3%). Complications were found in 19 patients (35.2%). MRE and US both showed high sensitivity (90.5 and 88.1%) and moderate specificity (50% in MRE and US) for detecting inflammation. MRE revealed higher sensitivity than US for detecting conglomerate tumors without statistical significance (85.7 vs. 71.4%, p=1.0) and equal specificity (97.9 vs 97.7, p=1.0). Therapeutic decisions included steroids in 20 patients (47.6%) and surgery/percutaneous drainage in six patients (14.3%), these decisions were triggered by results of US or MRE in equal distribution.

Conclusion US and MRE have comparable sensitivity and specificity for detecting intestinal inflammation and complications in IBD patients. Therefore, both methods are sufficient for making clinical decisions.

Supplementary Material



Publication History

Received: 15 September 2021

Accepted after revision: 30 January 2022

Article published online:
26 September 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Peyrin-Biroulet L, Sandborn W, Sands BE. et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. The American journal of gastroenterology 2015; 110: 1324-1338
  • 2 Kobayashi T, Siegmund B, Le Berre C. et al. Ulcerative colitis. Nature reviews Disease primers 2020; 6: 74 DOI: 10.1038/s41572-020-0205-x.
  • 3 Colombel JF, D’Haens G, Lee WJ. et al. Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review. Journal of Crohn’s & colitis 2020; 14: 254-266
  • 4 Navaneethan U, Parasa S, Venkatesh PG. et al. Prevalence and risk factors for colonic perforation during colonoscopy in hospitalized inflammatory bowel disease patients. Journal of Crohn’s & colitis 2011; 5: 189-195
  • 5 Calabrese E, Kucharzik T, Maaser C. et al. Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn’s Disease: An International Multicenter Study. Inflammatory bowel diseases 2018; 24: 2001-2006
  • 6 Allocca M, Fiorino G, Bonovas S. et al. Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study. Journal of Crohn’s & colitis 2018; 12: 1385-1391
  • 7 Bryant RV, Friedman AB, Wright EK. et al. Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. Gut 2018; 67: 973-985
  • 8 Panes J, Bouhnik Y, Reinisch W. et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. Journal of Crohn’s & colitis 2013; 7: 556-585
  • 9 Schulberg JD, Wright EK, Holt BA. et al. Magnetic resonance enterography for predicting the clinical course of Crohn’s disease strictures. Journal of gastroenterology and hepatology 2020; 35: 980-987
  • 10 Allocca M, Fiorino G, Bonifacio C. et al. Comparative Accuracy of Bowel Ultrasound Versus Magnetic Resonance Enterography in Combination With Colonoscopy in Assessing Crohn’s Disease and Guiding Clinical Decision-making. Journal of Crohn’s & colitis 2018; 12: 1280-1287
  • 11 Nylund K, Maconi G, Hollerweger A. et al. EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound. Ultraschall in Med 2017; 38: e1-e15
  • 12 Derlin T, Laqmani A, Veldhoen S. et al. Magnetic resonance enterography for assessment of intestinal graft-versus-host disease after allogeneic stem cell transplantation. Eur Radiol 2015; 25: 1229-1237
  • 13 Rutjes AW, Reitsma JB, Coomarasamy A. et al. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess 2007; 11: iii ix-51
  • 14 Valette PJ, Rioux M, Pilleul F. et al. Ultrasonography of chronic inflammatory bowel diseases. European radiology 2001; 11: 1859-1866
  • 15 Laterza L, Ainora ME, Garcovich M. et al. Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn’s disease patients undergoing anti-TNFalpha therapy. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2020; DOI: 10.1016/j.dld.2020.08.005:.
  • 16 Quaia E, Migaleddu V, Baratella E. et al. The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn’s disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. European journal of radiology 2009; 69: 438-444
  • 17 Taylor SA, Mallett S, Bhatnagar G. et al. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn’s disease (METRIC): a multicentre trial. The lancet Gastroenterology & hepatology 2018; 3: 548-558
  • 18 Maaser C, Petersen F, Helwig U. et al. Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study. Gut 2020; 69: 1629-1636
  • 19 Maaser C, Sturm A, Vavricka SR. et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn’s & colitis 2019; 13: 144-164